Literature DB >> 817629

A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study.

B Doster, G J Caras, D E Snider.   

Abstract

From 1961 through 1968 the incidence of primary drug resistance was monitored among patients admitted to 22 participating hospitals. The patients were believed to have newly diagnosed, previously untreated, bacteriologically proved pulmonary tuberculosis. During the study period the level of primary resistance to isoniazid, streptomycin, and para-aminosalicylic acid remained very low; there was no indication that primary resistance to these drugs was increasing. Investigation of patient histories revealed that a significant proportion of persons initially believed to have been previously untreated actually had received prior chemotherapy. Resistance rates to both isoniazid and streptomycin were significantly higher among younger patients than among older patients. No relationship was found between race or sex and primary resistance rates. The low incidence of drug resistance found in this survey suggests that disease caused by virulent resistant organisms occurs infrequently.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 817629     DOI: 10.1164/arrd.1976.113.4.419

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

1.  The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.

Authors:  M E Villarino; L J Geiter; P M Simone
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

Review 2.  Evolution of drug-resistant tuberculosis: a tale of two species.

Authors:  M D Iseman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

3.  Drug resistance among tuberculosis patients, New York City, 1991 and 1992.

Authors:  C R Driver; T R Frieden; A B Bloch; I M Onorato
Journal:  Public Health Rep       Date:  1994 Sep-Oct       Impact factor: 2.792

Review 4.  Tuberculosis in the AIDS era.

Authors:  K A Sepkowitz; J Raffalli; L Riley; T E Kiehn; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.